These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1977322)

  • 21. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of hyperglycaemia on isotopic measurement of glucose utilisation using [2(3)H], [3(3)H] and [6(14)C] glucose in patients with type 1 (insulin-dependent) diabetes mellitus.
    Bell PM; Firth RG; Rizza RA
    Diabetologia; 1987 Jun; 30(6):365-71. PubMed ID: 2890547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
    Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.
    Djurhuus CB; Gravholt CH; Nielsen S; Mengel A; Christiansen JS; Schmitz OE; Møller N
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E172-7. PubMed ID: 12067858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute cortisol excess results in unimpaired insulin action on lipolysis and branched chain amino acids, but not on glucose kinetics and C-peptide concentrations in man.
    Clerc D; Wick H; Keller U
    Metabolism; 1986 May; 35(5):404-10. PubMed ID: 3517554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
    Wasserman DH; Mohr T; Kelly P; Lacy DB; Bracy D
    Diabetes; 1992 Oct; 41(10):1229-38. PubMed ID: 1356861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects.
    Avogaro A; Gnudi L; Valerio A; Maran A; Miola M; Opportuno A; Tiengo A; Bier DM
    J Clin Endocrinol Metab; 1993 Apr; 76(4):845-50. PubMed ID: 8473394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recent, short-term hyperglycemia on responses to hypoglycemia in humans. Relevance to the pathogenesis of hypoglycemia unawareness and hyperglycemia-induced insulin resistance.
    Fanelli C; Pampanelli S; Calderone S; Lepore M; Annibale B; Compagnucci P; Brunetti P; Bolli GB
    Diabetes; 1995 May; 44(5):513-9. PubMed ID: 7729608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog.
    Shulman GI; Williams PE; Liljenquist JE; Lacy WW; Keller U; Cherrington AD
    Metabolism; 1980 Apr; 29(4):317-20. PubMed ID: 6103495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
    Vella A; Reed AS; Charkoudian N; Shah P; Basu R; Basu A; Joyner MJ; Rizza RA
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E25-30. PubMed ID: 12637258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.
    Boyle PJ; Avogaro A; Smith L; Shah SD; Cryer PE; Santiago JV
    Diabetologia; 1992 Apr; 35(4):372-9. PubMed ID: 1516766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis.
    Staehr P; Hother-Nielsen O; Landau BR; Chandramouli V; Holst JJ; Beck-Nielsen H
    Diabetes; 2003 Feb; 52(2):260-7. PubMed ID: 12540595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.